Genomics England: Chris Wigley

Chris Wigley has been appointed as CEO of Genomics England, effective October 1. He will replace current interim CEO Sir Mark Caulfield, who will remain the firm's chief scientist. Wigley will join Genomics England, which is wholly owned by the UK's Department of Health & Social Care, from QuantumBlack, a machine learning and artificial intelligence company, where he was chief operating officer. Prior to that, he was a partner at McKinsey, and before that, a diplomat with the British Foreign Office.